Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid

Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids

Aminoff, D. (1961) · Biochemical Journal · doi:10.1042/bj0810384 · Cited by 1,898

Application of a Microtechnique to Viral Serological Investigations

Sever, J. L. (1962) · The Journal of Immunology · doi:10.4049/jimmunol.88.3.320 · Cited by 1,615

Isolation of paramyxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein

Scheid, A., Caliguiri, L. A., Compans, R. W., & Choppin, P. W. (1972) · Virology · doi:10.1016/0042-6822(72)90418-7 · Cited by 325

Isolation and Purification of the Envelope Proteins of Newcastle Disease Virus

Scheid, A., & Choppin, P. W. (1973) · Journal of Virology · doi:10.1128/jvi.11.2.263-271.1973 · Cited by 293

Über 2-Desoxy-2.3-dehydro-sialinsäuren, II. Kompetitive Hemmung derVibrio-cholerae-Neuraminidase durch 2-Desoxy-2.3-dehyro-N-acyl-neuraminsäuren

Meindl, P., & Tuppy, H. (1969) · Hoppe-Seyler´s Zeitschrift für physiologische Chemie · doi:10.1515/bchm2.1969.350.2.1088 · Cited by 113

�ber 2-Deoxy-2,3-dehydro-sialins�uren, 1. Mitt.: Synthese und Eigenschaften von 2-Deoxy-2,3-dehydro-N-acylneuramins�uren und deren Methylestern

Meindl, P., & Tuppy, H. (1969) · Monatshefte für Chemie - Chemical Monthly · doi:10.1007/bf00903465 · Cited by 98

THE INHIBITION OF NEURAMINIDASE AND ANTIVIRAL ACTION

EDMOND, J. D., JOHNSTON, R. G., Kidd, D. A. A., Rylance, H. J., & Sommerville, R. G. (1966) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1966.tb01673.x · Cited by 62

Competitive inhibition of Vibrio cholerae neuraminic acids

Meindl, P. (1969) · Medical Entomology and Zoology · Cited by 61

Neuraminidase inhibition and viral chemotherapy

Haskell, T. H., Peterson, F. E., Watson, D., Plessas, N. R., & Culbertson, T. (1970) · Journal of Medicinal Chemistry · doi:10.1021/jm00298a027 · Cited by 51

Undisturbed release of influenza virus in the presence of univalent antineuraminidase antibodies

Becht, H., Hämmerling, U., & ROTT, R. (1971) · Virology · doi:10.1016/0042-6822(71)90035-3 · Cited by 51

Enzymatische zweistufige Synthese von N‐Acetylneuraminsäure im Enzym‐Membranreaktor

Kragl, U., Gygax, D., Ghisalba, O., & Wandrey, C. (1991) · Angewandte Chemie · doi:10.1002/ange.19911030721 · Cited by 38

Lysins

Hoshi, M. (1985) · Elsevier eBooks · doi:10.1016/b978-0-12-492602-8.50020-6 · Cited by 38

Correlation Analyses on Binding Affinity of Sialic Acid Analogues and Anti-Influenza Drugs with Human Neuraminidase Using ab Initio MO Calculations on Their Complex Structures – LERE-QSAR Analysis (IV)

Hitaoka, S., Matoba, H., Harada, M., Yoshida, T., Tsuji, D., Hirokawa, T., Itoh, K., & Chuman, H. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci2002395 · Cited by 37

Inhibition of human parainfluenza virus type 1 sialidase by analogs of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid

Suzuki, T., Ikeda, K., Koyama, N., Hosokawa, C., Kogure, T., Takahashi, T., Hidari, K. I. P. J., Miyamoto, D., Tanaka, K., & Suzuki, Y. (2001) · Glycoconjugate Journal · doi:10.1023/a:1013617232576 · Cited by 36

Structure‐Based Organic Synthesis of Drug Prototypes: A Personal Odyssey

Hanessian, S. (2006) · ChemMedChem · doi:10.1002/cmdc.200600203 · Cited by 36

Hydrophobic benzoic acids as inhibitors of influenza neuraminidase

Atigadda, V. R., Brouillette, W. J., Duarte, F. J., Babu, Y. S., Bantia, S., Chand, P., Chu, N., Montgomery, J. A. J., Walsh, D. A., Sudbeck, E. A., et al. (1999) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(99)00197-2 · Cited by 36

The synthesis of novel sialic acids as biological probes

von Itzstein, M., & Thomson, R. J. (1997) · Topics in current chemistry · doi:10.1007/bfb0119222 · Cited by 36

Mutations Affecting the Sensitivity of the Influenza Virus Neuraminidase to 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic Acid

Goto, H., Bethell, R. C., & Kawaoka, Y. (1997) · Virology · doi:10.1006/viro.1997.8810 · Cited by 36

Differential effect of various inhibitors on four types of rat sialidase

Miyagi, T., Hata, K., Hasegawa, A., & AOYAGI, T. (1993) · Glycoconjugate Journal · doi:10.1007/bf00731186 · Cited by 35

Inhibition of the neuraminidase of paramyxoviruses by halide ions: A possible means of modulating the two activities of the HN protein

Merz, D. C., Prehm, P., Scheid, A., & Choppin, P. W. (1981) · Virology · doi:10.1016/0042-6822(81)90635-8 · Cited by 34

Exploring the chemical space of influenza neuraminidase inhibitors

Anuwongcharoen, N., Shoombuatong, W., Tantimongcolwat, T., Prachayasittikul, V., & Nantasenamat, C. (2016) · PeerJ · doi:10.7717/peerj.1958 · Cited by 33

Synthesis of Pyrrolidine Analogues of N‐Acetylneuraminic Acid as Potential Sialidase Inhibitors

Czollner, L., Kuszmann, J., & Vasella, A. T. (1990) · Helvetica Chimica Acta · doi:10.1002/hlca.19900730522 · Cited by 33

Design of benzoic acid inhibitors of influenza neuraminidase containing a cyclic substitution for the N-acetyl grouping

Brouillette, W. J., Atigadda, V. R., Luo, M., Air, G. M., Babu, Y. S., & Bantia, S. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00318-2 · Cited by 32

The Origin and Control of Pandemic Influenza

Laver, W. G., Bischofberger, N., & Webster, R. G. (2000) · Perspectives in biology and medicine · doi:10.1353/pbm.2000.0008 · Cited by 32

Structural and functional-group tuning in the design of neuraminidase inhibitors

Sabesan, S., Neira, S., & Wasserman, Z. R. (1995) · Carbohydrate Research · doi:10.1016/0008-6215(94)00309-4 · Cited by 31

Chemoenzymatic synthesis of neuraminic acid analogs structurally varied at C-5 and C-9 as potential inhibitors of the sialidase from influenza virus

Murakami, M., Ikeda, K., & Achiwa, K. (1996) · Carbohydrate Research · doi:10.1016/0008-6215(95)00295-2 · Cited by 31

Glycophorin and Sialylated Components as Receptors for Viruses

Burness, A. T. H. (1981) · Springer eBooks · doi:10.1007/978-94-011-8022-1_4 · Cited by 31

trans-Sialidase activity for sialic acid incorporation on Corynebacterium diphtheriae

Mattos‐Guaraldi, A. L., Formiga, L. C. D., & Andrade, A. F. B. (1998) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(98)00280-8 · Cited by 30

Prevention and Control of Influenza by Chemoprophylaxis and Chemotherapy

Jackson, G. G. (1976) · JAMA · doi:10.1001/jama.1976.03260510033021 · Cited by 30

Synthesis of transition-state analogues as potential inhibitors of sialidase from Influenza virus

Driguez, P., Barrere, B., Quash, G., & Doutheau, A. (1994) · Carbohydrate Research · doi:10.1016/0008-6215(94)84186-1 · Cited by 30

Pyrrolidinobenzoic acid inhibitors of influenza virus neuraminidase: modifications of essential pyrrolidinone ring substituents

Brouillette, W. J., Bajpai, S. N., Ali, S. M., Velu, S. E., Atigadda, V. R., Lommer, B. S., Finley, J. B., Luo, M., & Air, G. M. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(03)00271-2 · Cited by 28

The interaction of substrate-related ketals with bacterial and viral neuraminidases

Flashner, M., Kessler, J., & Tanenbaum, S. W. (1983) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(83)90135-2 · Cited by 28

Structural Variations of N‐Acetylneuraminic Acid, 7. Synthesis of the C‐7‐, C‐8‐, and C‐7,8‐Side Chain Epimers of 2‐Deoxy‐2,3‐didehydro‐N‐acetylneuraminic Acid and Their Behaviour Towards Sialidase from Vibrio cholerae

Zbiral, E., Brandstetter, H. H., Christian, R., & Schauere, R. (1987) · Liebigs Annalen der Chemie · doi:10.1002/jlac.198719870828 · Cited by 28

Biological properties of a hemagglutinin mutant of influenza virus selected by host cells

Crecelius, D. M., Deom, C. M., & Schulze, I. T. (1984) · Virology · doi:10.1016/0042-6822(84)90337-4 · Cited by 27

Chemistry and Analysis of Sialic Acid

Ledeen, R. W., & Yu, R. K. (1976) · Springer eBooks · doi:10.1007/978-1-4684-2226-9_1 · Cited by 27

A cell-free assay for the insertion of a viral glycoprotein into the plasma membrane.

Woodman, P. G., & Edwardson, J. M. (1986) · The Journal of Cell Biology · doi:10.1083/jcb.103.5.1829 · Cited by 27

Sialic acid C-glycosides with aromatic residues: Investigating enzyme binding and inhibition of Trypanosoma cruzi trans-sialidase

Meinke, S., Schroven, A., & Thiem, J. (2011) · Organic & Biomolecular Chemistry · doi:10.1039/c0ob01176b · Cited by 26

Current landscape and future prospects of antiviral drugs derived from microbial products

Takizawa, N., & Yamasaki, M. (2017) · The Journal of Antibiotics · doi:10.1038/ja.2017.115 · Cited by 26

A Novel Potent and Highly Specific Inhibitor against Influenza Viral N1–N9 Neuraminidases: Insight into Neuraminidase–Inhibitor Interactions

Sriwilaijaroen, N., Magesh, S., Imamura, A., Ando, H., Ishida, H., Sakai, M., Ishitsubo, E., Hori, T., Moriya, S., Ishikawa, T., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01863 · Cited by 25

RWJ-270201 (BCX-1812): a novel neuraminidase inhibitor for influenza

Young, D. C., Fowler, C. L., & Bush, K. (2001) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2001.1004 · Cited by 26

The stereoselective formation of highly substituted CF 3 -dihydropyrans as versatile building blocks

Donslund, B. S., Monleón, A., Larsen, J., Ibsen, L., & Jørgensen, K. A. (2015) · Chemical Communications · doi:10.1039/c5cc04874e · Cited by 24

Trypanosoma Cruzi Trans -Sialidase as a Drug Target Against Chagas Disease (American Trypanosomiasis)

Miller, B. R., & Roitberg, A. E. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.129 · Cited by 24

Recent progress and challenges in the discovery of new neuraminidase inhibitors

Chamni, S., & De‐Eknamkul, W. (2013) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2013.765861 · Cited by 24

Inhibition of influenza A virus sialidase activity by sulfatide

Suzuki, T., Takahashi, T., Nishinaka, D., Murakami, M., Fujii, S., Hidari, K. I. P. J., Miyamoto, D., Li, Y., & Suzuki, Y. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01045-7 · Cited by 23

Susceptibility of different strains of influenza a virus to the inhibitory effects of 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA)

Schulman, J. L., & Palese, P. (1975) · Virology · doi:10.1016/0042-6822(75)90374-8 · Cited by 23

Structural Variations of N‐Acetylneuraminic Acid, 10. Synthesis of 2,7‐, 2,8‐, and 2,9‐Dideoxy‐ and 2,4,7‐Trideoxy‐2,3‐didehydro‐N‐acetylneuraminic Acids and Their Behavior Towards Sialidase from Vibrio cholerae

Zbiral, E., Schreiner, E. P., Christian, R., Kleineidam, R. G., & Schauer, R. (1989) · Liebigs Annalen der Chemie · doi:10.1002/jlac.198919890131 · Cited by 23

Synthesis and Evaluation of Indolizine‐Type Inhibitors of N‐acetyl‐β‐ D ‐glucosaminidases

Panday, N., Granier, T., & Vasella, A. T. (1998) · Helvetica Chimica Acta · doi:10.1002/hlca.19980810303 · Cited by 23

Intermolecular association of HANA glycoprotein of Sendai virus in relation to the expression of biological activities

Sugawara, K., Tashiro, M., & Homma, M. (1982) · Virology · doi:10.1016/0042-6822(82)90483-4 · Cited by 23

The design, synthesis and biological evaluation of neuraminic acid-based probes of Vibrio cholerae sialidase

Wilson, J. C., Thomson, R. J., Dyason, J. C., Florio, P., Quelch, K. J., Abo, S., & von Itzstein, M. (2000) · Tetrahedron Asymmetry · doi:10.1016/s0957-4166(99)00552-2 · Cited by 22

Neuraminidase-Dependent Degradation of Polysialic Acid Is Required for the Lamination of Newly Generated Neurons

Sajo, M., Sugiyama, H., Yamamoto, H., Tanii, T., Matsuki, N., Ikegaya, Y., & Koyama, R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146398 · Cited by 22

A Single Amino Acid Alteration in the Human Parainfluenza Virus Type 3 Hemagglutinin-Neuraminidase Glycoprotein Confers Resistance to the Inhibitory Effects of Zanamivir on Receptor Binding and Neuraminidase Activity

Murrell, M. T., Porotto, M., Greengard, O., Poltoratskaia, N., & Moscona, A. (2001) · Journal of Virology · doi:10.1128/jvi.75.14.6310-6320.2001 · Cited by 22

Taking aim at a moving target — inhibitors of influenza virus Part 2: viral replication, packaging and release

Meanwell, N. A., & Krystal, M. (1996) · Drug Discovery Today · doi:10.1016/1359-6446(96)10035-0 · Cited by 22

Host and Parasite Factors Affecting the Invasion of Mononuclear Phagocytes by Trypanosoma cruzi

Nogueira, N. (1983) · Novartis Foundation symposium · doi:10.1002/9780470720806.ch4 · Cited by 22

Combating influenza: natural products as neuraminidase inhibitors

Singh, N., Anjum, N., & Chandra, R. (2018) · Phytochemistry Reviews · doi:10.1007/s11101-018-9581-1 · Cited by 21

Mutation of Neuraminidase Cysteine Residues Yields Temperature-Sensitive Influenza Viruses

Basler, C. F., García‐Sastre, A., & Palese, P. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8095-8103.1999 · Cited by 22

The Biology of Sialic Acids: Insights into their Structure, Metabolism and Function in Particular during Viral Infection

Reutter, W. G., Stäsche, R., Stehling, P., & Baum, O. (1996) · doi:10.1002/9783527614738.ch13 · Cited by 21

Integration of neuraminidase inhibitor assay into a single-step operation using a combinable poly(dimethylsiloxane) capillary sensor

Ishimoto, T., Jigawa, K., Henares, T. G., Endo, T., & Hisamoto, H. (2013) · The Analyst · doi:10.1039/c3an36785a · Cited by 20

Cell Biological and Immunological Significance of Ganglioside Changes Associated with Transformation

Hakomori, S., Young, W. W., Patt, L. M., Yoshino, T., Halfpap, L., & Lingwood, C. A. (1980) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-7844-0_24 · Cited by 20

GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review

De Masi, R., & Orlando, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137373 · Cited by 20

Anti-Viral Inhibitor Binding to Influenza Neuraminidase by MALDI Mass Spectrometry

Swaminathan, K., & Downard, K. M. (2012) · Analytical Chemistry · doi:10.1021/ac300291c · Cited by 19

Neuraminidase inhibitors as antivirals

Colman, P. M. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00132-9 · Cited by 19

Biological consequences of neuraminidase deficiency in Newcastle disease virus

Smith, G. W., & Hightower, L. E. (1983) · Journal of Virology · doi:10.1128/jvi.47.3.385-391.1983 · Cited by 19

Approaches and Strategies for the Treatment of Influenza Virus Infections

Colacino, J. M., Staschke, K. A., & Laver, W. G. (1999) · Antiviral chemistry & chemotherapy · doi:10.1177/095632029901000402 · Cited by 19

Application of virus-like particles (VLP) to NMR characterization of viral membrane protein interactions

Antanasijevic, A., Kingsley, C. N., Basu, A., Bowlin, T. L., Rong, L., & Caffrey, M. S. (2016) · Journal of Biomolecular NMR · doi:10.1007/s10858-016-0025-1 · Cited by 18

Recent advances in the discovery and development of anti-influenza drugs

Wang, G. T. (2002) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.12.6.845 · Cited by 18

Synthesis of the 6‐C‐Methyl and 6‐C‐(Hydroxymethyl) Analogues of N‐Acetylneuraminic Acid and of N‐Acetyl‐2,3‐didehydro‐2‐deoxyneuraminic Acid

Vasella, A. T., & Wyler, R. (1990) · Helvetica Chimica Acta · doi:10.1002/hlca.19900730620 · Cited by 18

Sialidases and Their Inhibitors

Schauer, R., & Corfield, A. P. (1981) · Elsevier eBooks · doi:10.1016/b978-0-08-025297-1.50038-6 · Cited by 18

The sialidase inhibitor, DANA, reduces Porphyromonas gingivalis pathogenicity and exerts anti‐inflammatory effects: An in vitro and in vivo experiment

Yu, S., Fan, X., Zheng, S., Lin, L., Liu, J., Pan, Y., & Li, C. (2020) · Journal of Periodontology · doi:10.1002/jper.19-0688 · Cited by 17

Recent advances in the discovery and synthesis of neuraminidase inhibitors

Chand, P. (2005) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.15.8.1009 · Cited by 17

Neuraminidase Inhibitors as Potential Anti-Influenza Drugs

Bamford, M. J. (1995) · Journal of enzyme inhibition · doi:10.3109/14756369509021467 · Cited by 17

Synthesis of Sulfo-Sialic Acid Analogues: Potent Neuraminidase Inhibitors in Regards to Anomeric Functionality

Vavricka, C. J., Muto, C., Hasunuma, T., Kimura, Y., Araki, M., Wu, Y., Gao, G. F., Ohrui, H., Izumi, M., & Kiyota, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-07836-y · Cited by 16

Recent developments in the design of antiviral agents

Saunders, J., & Cameron, J. M. (1995) · Medicinal Research Reviews · doi:10.1002/med.2610150604 · Cited by 16

Purification and properties of Arthrobacter neuraminidase

Wang, P., Tanenbaum, S. W., & Flashner, M. (1978) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(78)90019-0 · Cited by 16

Inhibition of Viral Neuraminidase As a New Approach to the Prevention of Influenza* *This work was monitored by the Commission on influenza of the Armed Forces Epidemiological Board, and was supported (in part) by the U. S. Army Medical Research and Development Command under research contract No. DADA1769-C-9137, by Public Health Service research grant No. AI09304 from the National Institute of Allergy and Infectious Diseases, and by contract No. U-2076 from the Health Research Council of the City of New York.

Kilbourne, E. D., Palese, P., & Schulman, J. L. (1975) · Perspectives in virology · doi:10.1016/b978-0-12-560565-6.50014-0 · Cited by 16

Reaction of N-acetylneuraminic acid derivatives with perfluorinated anhydrides: a short access to N-perfluoracylated glycals with antiviral properties

Rota, P., Allevi, P., Mattina, R., & Anastasia, M. (2010) · Organic & Biomolecular Chemistry · doi:10.1039/c004938g · Cited by 15

1 Influenza Virus Sialidase: A Target for Drug Discovery

Kiefel, M. J., & von Itzstein, M. (1999) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(08)70044-4 · Cited by 15

Two evolutionary strategies of influenza viruses to escape host non-specific inhibitors: alteration of hemagglutinin or neuraminidase specificity

Gimsa, U., Grötzinger, I., & Gimsa, J. (1996) · Virus Research · doi:10.1016/0168-1702(96)01304-4 · Cited by 15

Specific inhibition of Trypanosoma cruzi neuraminidase by the human plasma glycoprotein "cruzin".

Prioli, R. P., Rosenberg, I. M., & Pereira, M. E. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.10.3097 · Cited by 15

Anti-Influenza Drug Discovery: Are We Ready for the Next Pandemic?

Islam, T. F., & von Itzstein, M. (2007) · Advances in carbohydrate chemistry and biochemistry · doi:10.1016/s0065-2318(07)61006-3 · Cited by 15

A photoreactive competitive inhibitor of the human lysosomal neuraminidase in cultured skin fibroblasts

Warner, T. G. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(87)80277-2 · Cited by 15

Structural variations of N‐acetylneuraminic acid, 9. A new useful approach to the epimers at C‐7 and C‐7,8 of N‐acetylneuraminic acid

Salunkhe, M., Hartmann, M., Schmid, W., & Zbiral, E. (1988) · Liebigs Annalen der Chemie · doi:10.1002/jlac.198819880215 · Cited by 15

A rational attack on influenza

Taylor, G. L. (1993) · Nature · doi:10.1038/363401a0 · Cited by 15

The reaction of the peracetate methyl esters of N-acetylneuraminic acid (Neu5Ac), 3-deoxy-d-glycero-d-galacto-2-nonulosonic acid (Kdn), and 3-deoxy-d-manno-2-octulosonic acid (Kdo) with trimethylsilyl trifluoromethanesulfonate

Kok, G. B., Mackey, B. L., & von Itzstein, M. (1996) · Carbohydrate Research · doi:10.1016/0008-6215(96)00120-6 · Cited by 15

Emerging antiviral resistant strains of influenza A and the potential therapeutic targets within the viral ribonucleoprotein (vRNP) complex

Davis, A. M., Chabolla, B. J., & Newcomb, L. L. (2014) · Virology Journal · doi:10.1186/1743-422x-11-167 · Cited by 14

Progress in structure-based drug design against influenza A virus

Du, Q.-S., Wei, H., Huang, R., & Chou, K. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.571671 · Cited by 14

Development of antivirals against influenza

Cianci, C., & Krystal, M. (1998) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.7.2.149 · Cited by 14

Neuraminidase inhibitors for influenza: a review and public health perspective in the aftermath of the 2009 pandemic

Beck, C., Sokal, R., Arunachalam, N., Puleston, R. L., Cichowska, A., Kessel, A. S., Zambon, M. C. F. A., Nguyen‐Van‐Tam, J. S., & on behalf of the UK Antiviral Effectiveness Review Group (2012) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12048 · Cited by 13

Synthesis and chemical characterization of several perfluorinated sialic acid glycals and evaluation of their in vitro antiviral activity against Newcastle disease virus

Rota, P., Papini, N., Rocca, P. L., Montefiori, M., Cirillo, F., Piccoli, M., Scurati, R., Olsen, L., Allevi, P., & Anastasia, L. (2017) · MedChemComm · doi:10.1039/c7md00072c · Cited by 13

Potent Inhibitors against Newcastle Disease Virus Hemagglutinin‐Neuraminidase

Rota, P., Rocca, P. L., Piccoli, M., Montefiori, M., Cirillo, F., Olsen, L., Orioli, M., Allevi, P., & Anastasia, L. (2017) · ChemMedChem · doi:10.1002/cmdc.201700755 · Cited by 13

Anti-influenza drugs and neuraminidase inhibitors

Roberts, N. A. (2001) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7784-8_2 · Cited by 13

A facile and direct entry to functionalised Neu5Ac2En derivatives from the methyl ketoside of Neu5Ac methyl esters

Kok, G. B., Groves, D. R., & von Itzstein, M. (1996) · Chemical Communications · doi:10.1039/cc9960002017 · Cited by 13

Anti-influenza drugs and neuraminidase inhibitors

Roberts, N. A. (2001) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8319-1_5 · Cited by 12

Design of Potential Neuraminidase Inhibitors By Dehydration, Deoxygenation and Epimerization of Siastatin B

Nishimura, Y., Kudo, T., Umezawa, Y., Kondo, S., & TAKEUCHI, T. (1992) · Natural product letters · doi:10.1080/10575639208048884 · Cited by 12

Discovery and development of oseltamivir at Gilead Sciences

Schmitz, U., & Swaminathan, S. (2022) · Antiviral Therapy · doi:10.1177/13596535211067598 · Cited by 11

Retracted and republished from: “The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs”

Li, Y., Huo, S., Yin, Z., Tian, Z., Huang, F., Liu, P., Liu, Y., & Yu, F. (2024) · mBio · doi:10.1128/mbio.00175-24 · Cited by 11

Parallel Screening of Wild-Type and Drug-Resistant Targets for Anti-Resistance Neuraminidase Inhibitors

Hsu, K., Hung, H., Horng, J., Fang, M., Chang, C., Li, L., Chen, I.-J., Chen, Y.-C., Chou, D.-L., Chun-Wei, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056704 · Cited by 11

A Strategy for Neuraminidase Inhibitors Using Mechanism‐Based Labeling Information

Hinou, H., Miyoshi, R., Takasu, Y., Kai, H., Kurogochi, M., Arioka, S., Gao, X., Miura, N., Fujitani, N., Omoto, S., et al. (2011) · Chemistry - An Asian Journal · doi:10.1002/asia.201000594 · Cited by 11

A facile synthesis of Neu5Ac2en derivatives from the glycosides of N-acetylneuraminic acid

Kok, G. B., Groves, D. R., & von Itzstein, M. (1999) · Journal of the Chemical Society Perkin Transactions 1 · doi:10.1039/a903047f · Cited by 11

Design and Synthesis of Sialidase Inhibitors for Influenza Virus Infections

Rich, J., Gehle, D., & von Itzstein, M. (2007) · Elsevier eBooks · doi:10.1016/b978-044451967-2/00107-0 · Cited by 10

Sialyl ligands facilitate lymphocyte accumulation during inflammation of the central nervous system

Simmons, R. D., & Cattle, B. A. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90062-p · Cited by 10

Sialoglycoproteins that bind influenza A virus and resist viral neuraminidase in different animal sera

Suzuki, T., Tsukimoto, M., Kobayashi, M., Yamada, A., Kawaoka, Y., Webster, R. G., & Suzuki, Y. (1994) · Journal of General Virology · doi:10.1099/0022-1317-75-7-1769 · Cited by 10

Stereoselective synthesis and transformation of siastatin B, A novel glycosidase inhibitor, directed toward new drugs for viral infection and tumor metastasis

Nishimura, Y. (1995) · Studies in natural products chemistry · doi:10.1016/s1572-5995(06)80053-0 · Cited by 10

A glycal-based photoaffinity probe that enriches sialic acid binding proteins

Thuy-Boun, P. S., & Wolan, D. W. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.07.054 · Cited by 9

Enzymatic glycosylation, inhibitor design, and synthesis and formation of glyco-self assembled monolayers for simulation of recognition

Scheppokat, A. M., Gerber, A., Schroven, A., Meinke, S., Kopitzki, S., Beketow, E., Thimm, J. C., & Thiem, J. (2009) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2009.11.017 · Cited by 9

Carbasugars: Synthesis and Functions

Kobayashi, Y. (2001) · Springer eBooks · doi:10.1007/978-3-642-56874-9_63 · Cited by 9

The Symmetry of Viral Sialic Acid Binding Sites–Implications for Antiviral Strategies

Rustmeier, N. H., Strebl, M., & Stehle, T. (2019) · Viruses · doi:10.3390/v11100947 · Cited by 9

Effect of some inhibitors on neuraminidase of Newcastle disease virus Kudu 113 strain

Oladele, S. B., Abdu, P. A., Nok, A. J., Akpofure, K., Esievo, N., & Useh, N. M. (2002) · Cited by 9

Update on Therapy of Influenza and Rhinovirus Infections

Arruda, E., & Hayden, F. G. (1996) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-9209-6_18 · Cited by 9

Trypanosomal Trans-sialidases: Valuable Synthetic Tools and Targets for Medicinal Chemistry

Meinke, S., & Thiem, J. (2012) · Topics in current chemistry · doi:10.1007/128_2012_330 · Cited by 8

Einfluß von 2-Desoxy-2.3-dehydro-N-acetylneuraminsäure auf Myxovirus-Neuraminidasen und die Replikation von Influenza- und Newcastle Disease Virus / Influence of 2-Deoxy-2,3-dehydro-N-acetylneuraminic Acid on Myxovirus-neuraminidases and the Replication of Influenza- and Newcastle Disease Virus

Meindl, P., Bodo, G., Lindner, J., & Palese, P. (1971) · Zeitschrift für Naturforschung B · doi:10.1515/znb-1971-0812 · Cited by 28

Acyl Amino Acid Derivatives as Novel Inhibitors of Influenza Neuraminidase

Kondoh, M., Furutani, T., Azuma, M., Ooshima, H., & Kato, J. (1997) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.61.870 · Cited by 13

Inhibition of influenza and parainfluenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA)

Palese, P., Schulman, J. L., Bodo, G., & Meindl, P. (1974) · Virology · doi:10.1016/0042-6822(74)90458-9 · Cited by 113

Inhibition Studies onVibrio choleraeNeuraminidase

Brossmer, R., KEILICH, G., & Ziegler, D. (1977) · Hoppe-Seyler´s Zeitschrift für physiologische Chemie · doi:10.1515/bchm2.1977.358.1.391 · Cited by 17

Inhibition of Influenza Virus Replication by 2-Deoxy-2,3-Dehydro-N-Trifluoroacetylneuraminic Acid (Fana)

Schulman, J. L., & Palese, P. (1976) · Springer eBooks · doi:10.1007/978-1-4684-3129-2_32